Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2017-04-27 | 2017-04-27 |
| Drug Identification Number | 02375893 | 02375893 |
| Brand name | POLYMYXIN B FOR INJECTION USP | POLYMYXIN B FOR INJECTION USP |
| Common or Proper name | POLYMYXIN B FOR INJECTION USP | POLYMYXIN B FOR INJECTION USP |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | POLYMYXIN B | POLYMYXIN B |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRATHECAL INTRAVENOUS OPHTHALMIC | INTRAMUSCULAR INTRATHECAL INTRAVENOUS OPHTHALMIC |
| Packaging size | 1 VIAL | 1 VIAL |
| ATC code | J01XB | J01XB |
| ATC description | OTHER ANTIBACTERIALS | OTHER ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2017-01-17 | 2017-01-17 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | BUSINESS REASONS | BUSINESS REASONS |
| Health Canada comments |